Sodium Acetate Injection Shortage: Current Availability and Manufacturer Updates
The FDA reports an ongoing shortage of Sodium Acetate Injection, used in Total Parenteral Nutrition, though Fresenius Kabi USA currently reports product availability.
Sodium Acetate Injection Shortage Update
What’s in Shortage
Generic Name: Sodium Acetate Injection
Brand Name: SODIUM ACETATE
Dosage Form: Injection
Therapeutic Category: Total Parenteral Nutrition
Current Status: Current Shortage
Initial Posting Date: March 23, 2016
Last Updated: February 5, 2026
Which Manufacturers Are Affected
The following manufacturer is listed in the FDA database regarding this shortage:
- Fresenius Kabi USA, LLC
- Status: Available
- Presentation: Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
- Notes: The manufacturer advises checking wholesalers for current inventory.
- Contact Information: 888-386-1300
Why There’s a Shortage
No specific reason for the shortage was provided in the source data.
What Patients Should Do
If you or a loved one relies on Sodium Acetate Injection as part of Total Parenteral Nutrition, please consider the following steps:
- Consult Your Healthcare Provider: Discuss your treatment plan with your doctor. Do not make any changes to your medical regimen without professional guidance.
- Talk to Your Pharmacist: Pharmacists can provide real-time updates on local stock and may be able to coordinate with wholesalers to secure supply.
- Contact the Manufacturer: For specific questions regarding supply, you may reach Fresenius Kabi USA at 888-386-1300.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider regarding medication changes or alternatives.
Source
Attribution: FDA Drug Shortage Database
Source: FDA Official Notice
Related Articles
Bacitracin Ophthalmic Ointment Shortage: Supply Issues Reported Due to Manufacturing Discontinuation
FDA · February 12, 2026
Valproate Sodium Injection Shortage: Current Availability and Manufacturer Updates
FDA · February 12, 2026
Lorazepam Injection Shortage: Current Availability and Manufacturer Updates
FDA · February 12, 2026